156 related articles for article (PubMed ID: 8400279)
1. Graft-versus-leukemia: no longer an epiphenomenon.
Antin JH
Blood; 1993 Oct; 82(8):2273-7. PubMed ID: 8400279
[No Abstract] [Full Text] [Related]
2. [Cellular immunotherapy in chronic myeloid leukemia].
Fernández MN
Sangre (Barc); 1998 Apr; 43(2):164-70. PubMed ID: 9656778
[No Abstract] [Full Text] [Related]
3. Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
Niederwieser D; Arcese W; Bandini G; Schwaighofer H; Thaler J; Bosi A; Di Bartolomeo P; Alessandrino EP; Urban C; Gratwohl A
Semin Hematol; 1993 Jul; 30(3 Suppl 3):40-3. PubMed ID: 8235706
[No Abstract] [Full Text] [Related]
4. Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia.
Champlin R
Exp Hematol; 1995 Oct; 23(11):1148-51. PubMed ID: 7556522
[No Abstract] [Full Text] [Related]
5. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
Hessner MJ; Endean DJ; Casper JT; Horowitz MM; Keever-Taylor CA; Roth M; Flomenberg N; Drobyski WR
Blood; 1995 Nov; 86(10):3987-96. PubMed ID: 7579370
[TBL] [Abstract][Full Text] [Related]
6. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
Porter DL; Roth MS; McGarigle C; Ferrara JL; Antin JH
N Engl J Med; 1994 Jan; 330(2):100-6. PubMed ID: 8259165
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow transplantation in chronic myeloid leukemia].
Hansz J
Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
[TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.
Miyamura K; Barrett AJ; Kodera Y; Saito H
Bone Marrow Transplant; 1994 Aug; 14(2):201-9. PubMed ID: 7994233
[TBL] [Abstract][Full Text] [Related]
9. Chronic graft-versus-host disease and seizure.
Azuno Y; Yaga K; Kaneko T; Kaku K; Oka Y
Blood; 1998 Apr; 91(7):2626-8. PubMed ID: 9516171
[No Abstract] [Full Text] [Related]
10. [Transplantation of the bone marrow to patients with chronic granulocytic leukemia].
Zduńczyk A
Wiad Lek; 1988 Dec; 41(24):1652-7. PubMed ID: 3076730
[No Abstract] [Full Text] [Related]
11. Indications for marrow transplantation in chronic myelogenous leukemia.
Thomas ED; Clift RA
Blood; 1989 Mar; 73(4):861-4. PubMed ID: 2645947
[No Abstract] [Full Text] [Related]
12. Treatment of chronic myeloid leukemia.
Beatty PG
Am J Med; 2001 Apr; 110(5):404-5. PubMed ID: 11286958
[No Abstract] [Full Text] [Related]
13. Expansion and activation of human natural killer cells for autologous therapy.
Miller JS; Verfaillie C; McGlave P
J Hematother; 1994; 3(1):71-4. PubMed ID: 7922011
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
[No Abstract] [Full Text] [Related]
15. Graft-versus-host reactions: anti-leukemia effects of donor T cells.
Flowers ME; Sullivan KM; Deeg HJ
Transplant Proc; 1996 Jun; 28(3):1184-5. PubMed ID: 8658620
[No Abstract] [Full Text] [Related]
16. The management of chronic myeloid leukaemia--a case history.
Sureda A; Hernández-Bronchud M
Ann Oncol; 1997 Jan; 8(1):91-6. PubMed ID: 9093713
[No Abstract] [Full Text] [Related]
17. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
[TBL] [Abstract][Full Text] [Related]
18. Vaginal stenosis with hematocolpometra, complicating chronic graft versus host disease.
Anguenot JL; Ibéchéole V; Helg C; Piacenza JM; Dumps P; Bonnefoi H
Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):185-7. PubMed ID: 12069746
[No Abstract] [Full Text] [Related]
19. Weight loss, skin rash, and cough following bone marrow transplantation for chronic myelogenous leukemia.
Witherspoon RP; McGlave P; Campbell JB; Sigley T; Rolston KV
Cancer Pract; 1998; 6(4):202-5. PubMed ID: 9767331
[No Abstract] [Full Text] [Related]
20. Modern management of chronic myelogenous leukemia (CML).
Feldman EJ; Arlin ZA
Cancer Invest; 1988; 6(6):737-42. PubMed ID: 3072996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
